FindTrial
Sign In

Effect of dexamethasone as adjuvant to ropivacaine in ultrasound guided transversus abdominis plane block in patients undergoing lower segment caesarean section

TO STUDY THE EFFECT OF DEXAMETHASONE ON DURATION AND QUALITY OF ANALGESIA WHEN USED AS AN ADJUVANT TO ROPIVACAINE IN ULTRASOUND GUIDED TRANSVERSUS ABDOMINIS PLANE BLOCK IN PATIENTS UNDERGOING LOWER SEGMENT CAESAREAN SECTION - A PROSPECTIVE, RANDOMIZED, SINGLE-BLINDED STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013146
Enrollment
90
Registered
2018-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PREGNANT FEMALES UNDERGOING ELECTIVE LOWER SEGMENT CAESAREAN SECTION

Interventions

Intervention1: GROUP R: ROPIVACAINE 0.375% 50 ML Control Intervention1: GROUP D: ROPIVACAINE 0.375% 50ML + DEXAMETHASONE 8 MG (2ML)

Sponsors

ANIE GUPTA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 18 YEARS AND ABOVE ASA GRADE II FEMALES UNDERGOING LOWER SEGMENT CAESAREAN SECTION

Exclusion criteria

Exclusion criteria: PATIENTS REFUSAL, EMERGENCY CAESAREAN SECTION,ALLERGY TO ANY OF THE DRUGS USED IN THE STUDY, INFECTION AT SITE OF THE BLOCK, ON ANTICOAGULANTS,DIABETICS,GENERAL ANAESTHESIA FOR CAESAREAN SECTION

Design outcomes

Primary

MeasureTime frame
TO COMAPARE THE TIME TO FIRST RESCUE ANALGESIA IN BOTH THE GROUPSTimepoint: FIRST RESCUE ANALGESIA—

Secondary

MeasureTime frame
TOTAL TRAMADOL CONSUMPTION POSTOPERATIVELY IN BOTH GROUPS POST OPERATIVE PAIN SCORES (VAS) FOR SOMATIC AND VISCERAL PAIN AT DESIGNATED TIME INTERVALS INCIDENCE OF NAUSEA NAD VOMITING ANY OTHER SIDE EFFECTSTimepoint: 24 HOURS ELAPSED AFTER THE SURGERY DEVELOPMENT OF TOXICITY TO ANY DRUG USED IN THE SUDY—

Countries

India

Contacts

Public ContactANIE GUPTA

max superspeciality hospital saket new delhi

dralok2005@yahoo.com9650070544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026